Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hohloch, K; Zinzani, PL; Linkesch, W; Jurczak, W; Deptala, A; Lorsbach, M; Windemuth-Kiesselbach, C; Wulf, GG; Truemper, LH.
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
Bone Marrow Transplant. 2011; 46(6): 901-903.
Doi: 10.1038/bmt.2010.202
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Linkesch Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Antibodies, Monoclonal - therapeutic use
-
Data Collection -
-
Female -
-
Hematopoietic Stem Cell Transplantation -
-
Humans -
-
Lymphoma, B-Cell - pathology
-
Male -
-
Middle Aged -
-
Radioimmunotherapy - methods
-
Transplantation, Autologous -
-
Treatment Outcome -
-
Young Adult -
-
Yttrium Radioisotopes - therapeutic use